Chemotherapy plus lenalidomide versus autologous transplantation, followed by lenalidomide plus prednisone versus lenalidomide maintenance, in patients with multiple myeloma: a randomised, multicentre, phase 3 trial

Clicks: 262
ID: 273814
2015
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
Celgene.
Reference Key
f2015thechemotherapy Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Gay F;Oliva S;Petrucci MT;Conticello C;Catalano L;Corradini P;Siniscalchi A;Magarotto V;Pour L;Carella A;Malfitano A;Petrò D;Evangelista A;Spada S;Pescosta N;Omedè P;Campbell P;Liberati AM;Offidani M;Ria R;Pulini S;Patriarca F;Hajek R;Spencer A;Boccadoro M;Palumbo A;;
Journal The Lancet. Oncology
Year 2015
DOI
DOI not found
URL
https://www.pubmed.gov/26596670/
Keywords
australia transplantation National Center for Biotechnology Information NCBI NLM MEDLINE chemotherapy humans pubmed abstract nih national institutes of health national library of medicine treatment outcome research support non-u.s. gov't female male aged middle aged Comparative Study risk factors Clinical Trial Phase III Randomized Controlled Trial Multicenter Study Proportional Hazards Models time factors autologous disease progression antineoplastic combined chemotherapy protocols / adverse effects disease-free survival prednisone / adverse effects kaplan-meier estimate maintenance chemotherapy dexamethasone / therapeutic use antineoplastic combined chemotherapy protocols / therapeutic use* cyclophosphamide / therapeutic use adjuvant italy Melphalan / therapeutic use antonio palumbo lenalidomide multiple myeloma / mortality thalidomide / adverse effects thalidomide / analogs & derivatives* thalidomide / therapeutic use pmid:26596670 doi:10.1016/s1470-2045(15)00389-7 francesca gay stefania oliva czech republic hematopoietic stem cell transplantation* / adverse effects hematopoietic stem cell transplantation* / mortality multiple myeloma / diagnosis multiple myeloma / therapy* prednisone / therapeutic use*

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.